Tag: Ocrelizumab

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Ocrelizumab

Most Real-World Studies Report Positive Outcomes of Rituximab Use in Multiple Sclerosis

Added to Collection on: 2024-05-08 17:49:54

Tags for this article:

Orphan drugs
Multiple sclerosis
Rituximab
Autoimmune diseases
Monoclonal antibodies
CD20
Management of multiple sclerosis
Biosimilar
Ocrelizumab
Non-Hodgkin lymphoma
Biogen
Genentech

Click the tags to see associated articles and topics

View Article Details
Roche's Ocrevus Subcutaneous Gets European Commission Nod By Benzinga

Added to Collection on: 2024-06-26 17:25:05

Tags for this article:

Biotechnology
Corvallis, Oregon
Sarepta Therapeutics
Delandistrogene moxeparvovec
Duchenne muscular dystrophy
Ocrelizumab
Roche
Gene therapy
Multiple sclerosis
Therapy
Accelerated approval

Click the tags to see associated articles and topics

View Article Details
Roche's Ocrevus Subcutaneous Gets European Commission Nod | Markets Insider

Added to Collection on: 2024-06-26 17:09:16

Tags for this article:

Biotechnology
Corvallis, Oregon
Sarepta Therapeutics
Delandistrogene moxeparvovec
Duchenne muscular dystrophy
Ocrelizumab
Roche
Gene therapy
Multiple sclerosis
Therapy
Accelerated approval

Click the tags to see associated articles and topics

View Article Details
Halozyme Announces Roche's OCREVUS SC with ENHANZE Receives European ...

Added to Collection on: 2024-06-26 14:23:12

Tags for this article:

Multiple sclerosis
Ocrelizumab
Subcutaneous administration
Drug delivery
Roche
Pharmaceutical industry
Halozyme Therapeutics Inc.
SAN DIEGO

Click the tags to see associated articles and topics

View Article Details
Roche price target raised to CHF 250 from CHF 240 at Jefferies - TipRanks.com

Added to Collection on: 2024-07-03 14:23:57

Tags for this article:

Monoclonal antibodies
Ocrelizumab
Roche
Multiple sclerosis
Human papillomavirus infection
CHMP

Click the tags to see associated articles and topics

View Article Details
Halozyme Announces FDA Approval of Roche's Subcutaneous OCREVUS ZUNOVO™ with ...

Added to Collection on: 2024-09-14 05:24:04

Tags for this article:

Ocrelizumab
Genentech
Multiple sclerosis
Dosage forms
Roche
Subcutaneous administration
Pharmaceutical industry
Food and Drug Administration
Drug delivery
Pfizer
Halozyme Therapeutics Inc.
SAN DIEGO

Click the tags to see associated articles and topics

View Article Details
FDA approves Roche's injectable version of blockbuster multiple sclerosis drug

Added to Collection on: 2024-09-14 15:08:25

Tags for this article:

Genentech
Roche
South San Francisco, California
Ocrelizumab
Multiple sclerosis
Novartis
Pharmaceutical industry

Click the tags to see associated articles and topics

View Article Details
Study Casts Doubt on Benefit of Anti-CD20 Therapies in Multiple Sclerosis - BioSpace

Added to Collection on: 2024-09-26 12:36:35

Tags for this article:

Multiple sclerosis
Autoimmune diseases
Ocrelizumab
Management of multiple sclerosis
Rituximab
Ofatumumab
CD20
Multiple sclerosis drug pipeline
Research in multiple sclerosis

Click the tags to see associated articles and topics

View Article Details
Monoclonal Antibody Therapy in Childhood Helps Reduce Long-Term MS Disability

Added to Collection on: 2024-10-02 15:52:51

Tags for this article:

Multiple sclerosis
Autoimmune diseases
Monoclonal antibodies
Research in multiple sclerosis
Ocrelizumab
Natalizumab
Expanded Disability Status Scale
Monoclonal antibody therapy
Antibody therapy
Inflammatory demyelinating diseases of the central nervous system
Multiple sclerosis drug pipeline

Click the tags to see associated articles and topics

View Article Details
Indapta Therapeutics: $22.5 Million Raised For Advancing Clinical Trials Of Cancer And ... - Pulse 2.0

Added to Collection on: 2024-12-24 18:50:24

Tags for this article:

Clusters of differentiation
Multiple myeloma
CD20
Cancer immunotherapy
CD38
Ocrelizumab
Natural killer cell
Autoimmunity
Isatuximab
Bayer AG
Indapta

Click the tags to see associated articles and topics

View Article Details